Literature DB >> 26507840

Recurrent episodes of night blindness in a patient with short bowel syndrome.

Agnes B Renner1, Tina Dietrich-Ntoukas2,3, Herbert Jägle2.   

Abstract

PURPOSE: To describe clinical characteristics in a patient with recurrent episodes of night blindness due to vitamin A deficiency caused by short bowel syndrome in Crohn disease.
METHODS: Retrospective analysis of best-corrected visual acuity (BCVA), kinetic perimetry, slit-lamp biomicroscopy, ophthalmoscopy, fundus photography, fundus autofluorescence (FAF), spectral domain optical coherence tomography (SD-OCT), dark adaptometry (DA) and electroretinography (ERG). Serum vitamin A level was measured.
RESULTS: A 44-year-old man with a 3-year history of night blindness suffered from a short bowel syndrome with chronic malabsorption due to ileocecal resection in Crohn disease. Both eyes had a BCVA of 0.9, Bitot's spots of the conjunctiva and no significant fundus abnormalities. SD-OCT showed no remarkable changes, whereas FAF was brighter than normal in the center of the fovea. DA showed normal cone and a lack of rod function. The dark-adapted 0.01 ERG was non-detectable, the dark-adapted 3.0 ERG severely diminished, but the light-adapted 3.0 and 30 Hz flicker ERGs were within normal limits. Serum vitamin A level was 0.11 µg/ml (normal 0.30-0.65 µg/ml). Treatment with intravenous vitamin A caused a rapid recovery of night vision and ERG. However, during the following 3 years, he had three further episodes of night blindness with loss of rod function. During each period, parenteral vitamin A substitution brought complete recovery of night vision and rod function. BCVA, fundus, FAF findings and SD-OCT remained unchanged during the course.
CONCLUSIONS: In patients with known chronic malabsorption serum vitamin A level should be regularly checked to avoid recurrent night blindness episodes. ERG might be more sensitive than serum vitamin A level and is recommended in case of night blindness but still normal vitamin A level.

Entities:  

Keywords:  Bitot’s spots; Dark adaptometry; Electroretinography; Fundus autofluorescence; Short bowel syndrome; Vitamin A deficiency

Mesh:

Substances:

Year:  2015        PMID: 26507840     DOI: 10.1007/s10633-015-9516-8

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  37 in total

1.  TAUTOMERIC FORMS OF METARHODOPSIN.

Authors:  R G MATTHEWS; R HUBBARD; P K BROWN; G WALD
Journal:  J Gen Physiol       Date:  1963-11       Impact factor: 4.086

2.  Optical density spectra of the macular pigment in vivo and in vitro.

Authors:  R A Bone; J T Landrum; A Cains
Journal:  Vision Res       Date:  1992-01       Impact factor: 1.886

3.  Acquired subretinal flecks secondary to hypovitaminosis A in a patient with hepatitis C.

Authors:  Jasmine R Elison; Alan H Friedman; Scott E Brodie
Journal:  Doc Ophthalmol       Date:  2004-11       Impact factor: 2.379

4.  ISCEV Standard for full-field clinical electroretinography (2008 update).

Authors:  M F Marmor; A B Fulton; G E Holder; Y Miyake; M Brigell; M Bach
Journal:  Doc Ophthalmol       Date:  2008-11-22       Impact factor: 2.379

5.  Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies.

Authors:  Richard G Weleber; Robert C Watzke; William T Shults; Karmen M Trzupek; John R Heckenlively; Robert A Egan; Grazyna Adamus
Journal:  Am J Ophthalmol       Date:  2005-05       Impact factor: 5.258

6.  Night blindness and Crohn's disease.

Authors:  Breno da Rocha Lima; Francesco Pichi; Careen Y Lowder
Journal:  Int Ophthalmol       Date:  2014-04-09       Impact factor: 2.031

7.  Gyrate atrophy: clinical and genetic findings in a female without arginine-restricted diet during her first 39 years of life and report of a new OAT gene mutation.

Authors:  Agnes B Renner; Andreas Walter; Britta S Fiebig; Herbert Jägle
Journal:  Doc Ophthalmol       Date:  2012-06-07       Impact factor: 2.379

8.  Vitamin A deficiency associated with urinary retinol binding protein wasting in Dent's disease.

Authors:  Rachel Becker-Cohen; Choni Rinat; Efrat Ben-Shalom; Sofia Feinstein; Heftziba Ivgi; Yaacov Frishberg
Journal:  Pediatr Nephrol       Date:  2012-02-19       Impact factor: 3.714

9.  Xerophthalmia--a potential epidemic on our doorstep?

Authors:  S McLaughlin; J Welch; E MacDonald; S Mantry; K Ramaesh
Journal:  Eye (Lond)       Date:  2014-02-14       Impact factor: 3.775

10.  Xerophthalmia and acquired night blindness in a patient with a history of gastrointestinal neoplasia and normal serum vitamin A levels.

Authors:  Anastasios Anastasakis; Sotiris Plainis; Trisevgeni Giannakopoulou; Elisavet Papadimitraki; Charalambos Fanouriakis; Miltiadis K Tsilimbaris
Journal:  Doc Ophthalmol       Date:  2013-01-20       Impact factor: 2.379

View more
  5 in total

Review 1.  Management and Complications of Short Bowel Syndrome: an Updated Review.

Authors:  Robert E Carroll; Enrico Benedetti; Joseph P Schowalter; Alan L Buchman
Journal:  Curr Gastroenterol Rep       Date:  2016-07

2.  Vitamin A deficiency after prolonged intake of an unbalanced diet in a Japanese hemodialysis patient.

Authors:  Nanami Kishimoto; Takaaki Hayashi; Kei Mizobuchi; Masaomi Kubota; Tadashi Nakano
Journal:  Doc Ophthalmol       Date:  2021-02-05       Impact factor: 2.379

3.  Serum carotenoids and macular pigment optical density in patients with intestinal resections and healthy subjects: an exploratory study.

Authors:  Jane N Eriksen; August P Prahm; Mads Krüger Falk; Eva Arrigoni; Palle B Jeppesen; Michael Larsen; Lars O Dragsted
Journal:  J Nutr Sci       Date:  2018-02-05

4.  Xerophthalmia: Findings from the Eye Lead to Diagnosis of a Fatal Intestinal Disease.

Authors:  Beril Tulu Aygun; Burcin Kepez Yildiz; Deniz Ogutmen Koc; Yusuf Yildirim
Journal:  Beyoglu Eye J       Date:  2020-07-29

Review 5.  Dark Adaptation and Its Role in Age-Related Macular Degeneration.

Authors:  Archana K Nigalye; Kristina Hess; Shrinivas J Pundlik; Brett G Jeffrey; Catherine A Cukras; Deeba Husain
Journal:  J Clin Med       Date:  2022-03-01       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.